Search

everythinglearnresearchcommunity

for

Search:↓

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Abietic acid from pine resin can effectively inhibit testosterone 5α-reductase.

The patient has frontal fibrosing alopecia (FFA).

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.